穴位埋线联合麻杏石甘汤加味防治支气管哮喘的临床研究

A clinical study on treating bronchial asthma in TCM

目的:通过观察穴位埋线联合麻杏石甘汤加味防治支气管哮喘临床疗效,评价冬病夏治干预效果。方法:选择本院收治的支气管哮喘患者60例作为研究对象,按照数字随机法分为两组,每组30例,观察组采取穴位埋线联合麻杏石甘汤加味治疗,对照组单纯采取麻杏石甘汤加味治疗,观察两组疗效差异。结果:观察组治愈15例(50.0%),好转10例(33.3%),部分缓解3例(10.0%),总有效为28例(93.3%),明显优于对照组25例(83.3%),差异显著,P<0.05;两组患者治疗前FVC、FEV1、FEV1(L)/FVC(%)、咳嗽、胸闷、痰量积分均无明显差异,P>0.05;治疗后观察组FVC、FEV1、FEV1(L)/FVC(%)分别为(3.79±0.79)L、(3.09±0.65)L、(86.79±9.76)%,均优于对照组,均P<0.05;治疗后,观察组咳嗽、胸闷、痰量积分分别为(1.24±0.39)分、(1.19±0.37)分、(1.09±0.31)分,均明显优于对照组,均P<0.05。结论:穴位埋线联合麻杏石甘汤加味防治支气管哮喘效果较佳,对缓解临床症状、体征均有重要价值。

Objective:To observe clinical of TCM therapy on bronchial asthma. Methods:60 patients were randomly divided into two groups, the observation group was given acupoint catgut embedding plus the Maxing Shigan decoction, and the control group was given the Maxing Shigan decoction solo. Results: In the observation group, 15 (50.0%) cases were cured, 10 (33.3%) were improved, 3 (10.0%) were partial remission, and the total efficacy was 93.3%, significantly better than the 83.3% in the control, with significant difference, P<0.05; FVC, FEV1, FEV1(L)/FVC(%), cough, chest tightness, sputum volume integral in two groups without obvious difference before treatment, P>0.05;after treatment, those were better, P<0.05. Conclusion:TCM therapy shows good effects on bronchial&nbsp;asthma, and is worthy of clinical promotion.